Riskpilot← Back to searchSign inGet full accessCurara AB
ABActiveOrg 5568056161Vanadisvägen 22 BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20100 employees
Revenue 2024
SEK 104K
0% vs 2023
EBITDA margin
-167.8%
+74% vs 2023
Equity ratio
23.7%
Financial strength
Net profit 2024
SEK -174K
+71% vs 2023
| Revenue | SEK 104K | +0% |
| EBITDA | SEK -175K | +74% |
| Net profit | SEK -174K | +71% |
| Total assets | SEK 182K | -75% |
| Equity | SEK 43K | -60% |
| Employees | 0 | — |
Legal name
Curara AB
Org number
5568056161
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19 april 2010
Share capital
SEK 52 500
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska driva forskning och läkemedelsutveckling och därmed förenlig verksamhet.
Address
Vanadisvägen 22 B
Email
lars.klareskog@ki.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 254 | 598 | 104 | 104 |
| Staff expenses | — | — | — | −209 | −0 |
| EBITDA | −206 | 1 120 | 332 | −662 | −175 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | −206 | 1 120 | 332 | −662 | −175 |
| Net financials | — | — | — | −0 | 1 |
| Profit before tax | −206 | 585 | 63 | −607 | −174 |
| Tax | −0 | −25 | −13 | — | — |
| Net profit | −206 | 560 | 50 | −607 | −174 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 131 | 1 137 | 1 162 | 718 | 182 |
| Equity | 59 | 619 | 669 | 107 | 43 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 72 | 482 | 438 | 611 | 139 |
| Total debt | 72 | 482 | 438 | 611 | 139 |
EBITDA margin
-167.8%
This company
15.8%
Market median
-1162% vs market
20202024
Equity ratio
23.7%
This company
38.2%
Market median
-38% vs market
20202024
Return on equity
-403.6%
This company
18.4%
Market median
-2293% vs market
20202024
Net profit margin
-166.7%
This company
8.1%
Market median
-2158% vs market
20202024
Asset turnover
0.57×
This company
1.12×
Market median
-49% vs market
20202024
Debt / equity
3.21×
This company
0.62×
Market median
-418% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CT Audit | Audit | 2020 |
| Former (1) | ||
JM Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Curara AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claes Tobias Benne | Audit | 0 companies |
| Jan Martin Steinberg | Chief Executive Officer | 0 companies |
| Inger Vivianne Malmström | Deputy Board Member | 0 companies |
| Lars Göran Yngve Klareskog | Board of Directors | 0 companies |
| Daniel Ola Steinberg | Deputy Board Member | 0 companies |